One in Four Patients Die Within One Year of First Heart Failure Hospitalization
2023-06-30
AHA会议
FRIDAY, June 30, 2023 -- Globally, one in four heart failure patients die within the first year of their first heart failure-related hospitalization, according to a study published online June 21 in JACC: Heart Failure.
Biykem Bozkurt, M.D., Ph.D., from Baylor College of Medicine in Houston, and colleagues described rehospitalizations, hospitalization costs, use of guideline-directed medical therapy, and mortality after hospitalization for heart failure. Analysis included electronic health record or claims data for 263,525 adult patients in Japan, Sweden, the United Kingdom, and the United States with a first heart failure discharge between 2018 and 2022.
The researchers found that 28 percent of patients died within the first year posthospitalization heart failure (event rate: 28.4). Heart failure (event rate: 13.6) and chronic kidney disease (CKD; event rate: 4.5) drove rehospitalizations. Similarly, heart failure and CKD drove health care costs. There was little change seen between 2020 and 2022 for use of renin-angiotensin system inhibitorsrenin-angiotensin system inhibitors, sacubitril/valsartan, beta-blockers, and mineralocorticoid receptor antagonists. However, uptake of sodium-glucose cotransporter-2 inhibitorssodium-glucose cotransporter-2 inhibitors increased two- to sevenfold.
"Incident posthospitalization heart failure rehospitalization risks and costs were high, and guideline-directed medical therapy use changed little in the year following discharge, highlighting the need to consider earlier and greater implementation of guideline-directed medical therapy to manage risks and reduce costs," the authors write.
Several authors disclosed ties to the pharmaceutical industry. Medical writing support was provided by AstraZeneca, which also funds EVOLUTION HF, the longitudinal cohort study from where the data was pulled.
Abstract/Full Text
Posted June 2023
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。